Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Paclitaxel derivatives developed at Bristol-Myers Squibb

July 11, 1997

Sparta's Spartaject busulfan enters phase I

July 11, 1997

GeneMedicine and UCSF enter into gene therapy collaboration

July 11, 1997

Banyu claims farnesyltransferase inhibitors

July 11, 1997

New antitumor taxanes from Yakult Honsha

July 11, 1997

Hycamtin launched in Canada

July 10, 1997

Kyowa Hakko develops cell adhesion inhibitors

July 10, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Novel antitumor agents from Sanwa Kagaku

July 9, 1997

CarboMed licenses broad-spectrum anticancer agent to Zeneca

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...